COVID-19 Pharmacological Management
Cardiovascular Medications

Cardiovascular Medications

ACE Inhibitors or ARBs

Patients with indication for cardiovascular disease should continue these medications unless there is evidence of acute kidney injury

HMG-CoA Reductase Inhibitors (Statins)

Patients who are prescribed statin therapy for the treatment or prevention of cardiovascular disease should continue these medications